Market Tracker

10/20 4:45pm ET

ImmunoGen Inc (NASDAQ:IMGN)

9.46
Data as of Oct 20
 +1.16 / +13.98%
Today’s Change
7.70
Today|||52-Week Range
18.19
-35.51%
Year-to-Date

Today’s Trading

Previous close8.30
Today’s open8.49
Day’s range8.41 - 9.70
Volume2,163,388
Average volume (3 months)995,058
Market cap$713.1M
Dividend yield--
Data as of 3:59pm ET, 10/20/2014

Growth & Valuation

Earnings growth (last year)+4.60%
Earnings growth (this year)+13.40%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+68.55%
P/E ratioNM
Price/Sales16.91
Price/Book9.42

Competitors

 Today’s
change
Today’s
% change
FMIFoundation Medicine ...-0.43-1.88%
RLYPRelypsa Inc+0.38+2.03%
MNTAMomenta Pharmaceutic...-0.14-1.23%
BCRXBioCryst Pharmaceuti...+0.02+0.17%
Data as of 3:59pm ET, 10/20/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$59.9M
Annual profit (last year)-$71.4M
Net profit margin-119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts